WHO-ART. Magnus Wallberg. November 24 th 2009 Dar Es Salaam, Tanzania.

Similar documents
Terminologies for recording of ADR:s

Training Course for Introducing Pharmacovigilance of HIV Medicines: November at the White Sands Hotel, Dar es Salaam, Tanzania.

Overview of the MedDRA Data Retrieval and Presentation: Points to Consider Document including Standardised MedDRA Queries (SMQs)

MedDRA Overview A Standardized Terminology

What s New MedDRA Version 13.1

What s New MedDRA Version March

What s New MedDRA Version March

What s New MedDRA Version MSSO-DI March 2016

MedDRA Basic Concept

Data retrieval using the new SMQ Medication Errors

MedDRA 13.0 Review. General Remarks. Version 13.0 Changes Overview. Changes in a Nutshell. Changes Highlights. MedDRA Version Changes

Data Analysis and Query Building with MedDRA

What s New MedDRA Version 18.0

What s New MedDRA Version 15.1

Automatic extraction of adverse drug reaction terms from medical free text

Farmakovijilans ve MedDRA Pharmacovigilance and MedDRA FARMAKOVİJİLANS ve FARMAKOVİJİLANS UYGULAMALARI EKİM Dr.

Proposed MedDRA Version 17.0 Complex Changes (July 2013)

MedDRA - International standard for coding safety information. The Golden Triangle

Best practices in VeDDRA coding

Principles of Signal Detection. Pia Caduff-Janosa MD Annual Course May 2013

Perspective: E2B transmission

What s New MedDRA Version 14.0

EMEA PUBLIC STATEMENT ON PARECOXIB SODIUM (Dynastat/Rayzon/Xapit) RISK OF SERIOUS HYPERSENSITIVITY AND SKIN REACTIONS

Case Series Drug Analysis Print Name: Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine 01Sep Oct2014

Advanced MedDRA Coding

MedDRA 14.0 Review MedDRA Version Changes General Remarks MedDRA Version 14.0 Specific Changes Version 14.0 Changes Overview Changes in a Nutshell

MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER

Medical Questionnaire

medical questionnaire Date: Day Month Year

MedDRA Coding Quality: How to Avoid Common Pitfalls

Drug Safety Monitoring in a Prepandemic and Pandemic Avian Flu Mass Vaccination Scenario

Name(last, first): Home Phone: Cell Phone: address: Date of birth: SSN:

Data Analysis and Query Building with MedDRA

Introduction to MedDRA

MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER

PLEASE COMPLETE ALL SECTIONS OF THIS FORM

Implemented MedDRA Version 22.0 Complex Changes (October 2018)

Trainee Assessment Demonstrate knowledge of the ageing process and its effects on individual support needs. US V2 Level 3 Credits 7 Name..

MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER

Patient Name: First MI Last Preferred Name. DOB: Sex: MALE FEMALE SSN: Address: Address: Relationship: Address:

Episodes of Care Risk Adjustment

MedDRA 10.1 Review. MedDRA Version 10.1 What s coming ahead? MedDRA Version Changes. General Remarks. Terminology Files: What you need to know

MedDRA Coding and Versioning

Introductory Guide MedDRA Version 15.0

Cell Phone #: Home Phone #: ** Address (prefer your forever address):

Full Novartis CTRD Results Template

IF YOU HAVE A MEDICAL LIST WITH YOU, PLEASE SUBMIT IT WITH THIS FORM.

New Patient Information

ADVERSE DRUG REACTION REPORTS IN MALAYSIA: COMPARISON OF CAUSALITY ASSESSMENTS

MIDDLE TOWNSHIP PUBLIC SCHOOLS CAPE MAY COURT HOUSE, NJ CURRICULUM GUIDE DISCIPLINE: Medical Terminology GRADE LEVEL: 11-12

Center for Advanced Wound Care New Patient Questionnaire Page 1 of 6

Past Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1

MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER

Island Acupuncture. Patient General Information. Last Name First Name. Home Phone Cell Phone. Work Phone . Date of Birth Occupation

Getting started with PROMACTA (eltrombopag)

School Curriculum and Standards Authority

1.1. An overview of reports on sitagliptin

New Patient Information Form

Use of MedDRA in Special Situations

PFIZER INC. PROTOCOL TITLE: Growth hormone therapy in short children after renal transplantation for chronic renal failure in Germany.

Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority?

An overview of reports on lacosamide

Brewster Chiropractic Michael B. Singleton DC, MS, CNS, CSCS

Introductory Guide MedDRA Version 14.0

SCIENTIFIC DISCUSSION

KEY TO LIFE CHIROPRACTIC

Safety Data Analysis and Query Creation with MedDRA

DIVISION OF CARDIOLOGY

Synopsis Style Clinical Study Report SR EFC10139 Version number: 1 (electronic 2.0)

Patient Name: First MI Last Preferred Name. DOB: Sex: MALE FEMALE SSN: Address: City: State: Zip Code:

LECOM Health Ophthalmology

Preferred phone: Best time to call you: Morning Afternoon Evening

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN TETANUS IMMUNOGLOBULIN FOR INTRAMUSCULAR USE (CPMP/BPWG/3730/02)

Model Questions for Core Course

Patient Health History

Coding with MedDRA 3/6/2019

Fast, Easy, Accurate, and Affordable

Sponsor Novartis. Generic Drug Name Pasireotide. Therapeutic Area of Trial Cushing s disease. Protocol Number CSOM230B2208E1

Information from Uppsala Monitoring Centre regarding cases in VigiBase

What Medical Writers Need to Know About MedDRA

24-7 Emergency line service (English)

NEW PATIENT FORM. Please print in ink and fill in all blanks Please fill out front and back. Patient s Full Name

NEW PATIENT VISIT QUESTIONNAIRE

NEUROLOGICAL SURGERY, P.C.

#5411 Educational Leadership: Administration and Supervision. #5135: Art: Content & Analysis Knowledge. #5101 Business Education: Content Knowledge

Pharmacovigilance Working Party (PhVWP)

NEW ZEALAND DATA SHEET

AT235 Middle Ear Analyzer. Diagnostic & clinical tympanometry with basic audiometry

UNGASS 2016 Global Civil Society Survey

MedDRA Coding/ AE Log Item 1 Refresher. ASPIRE Protocol Team Meeting February 10, 2013

Cetirizine Proposed Core Safety Profile

20 June 2018 Our Ref: RFI 23569

Search for studies: ClinicalTrials.gov Identifier: NCT

Background. events and processes leading up to this meeting

J. Van Lier Ribbink, M.D., F.A.C.S. Center for Endocrine and Pancreas Surgery at Honor Health

Routine signal detection and statistical tools on paediatrics

Patient Information. Account #: Date: Person Responsible For Payment (Other than patient):

Innovation and Regulatory Review What is JumpStart?

Chiropractic History

Transcription:

WHO-ART Magnus Wallberg November 24 th 2009 Dar Es Salaam, Tanzania magnus.wallberg@who-umc.org

WHO-ART (WHO-Adverse Reaction Terminology)

The need for a medical terminology dyspnoea? tinnitus ARDS fever feeling high mood swings breath shortness? unconsciousness heart disorder headache SOB somnolence rash

General requirements Data entry: Data retrieval: Other: comprehensive specific consistent user friendly flexible accurate consistent user friendly multilingual definitions computer adaptation continous updating

WHO-ART Developed for the WHO Drug Monitoring Programme in use for 40 years for adverse reaction monitoring NOT for indications, tests, background diseases etc. used by both regulatory agencies and pharmaceutical manufacturers maintained by the UMC

WHO-ART cont. 4 level hierarchial structure New terms added when necessary Created in English Translations in French, German, Italian, Spanish, Portuguese (Chinese, Japanese, Korean, Russia) Paper print, CD and electronical version Latest version available in VigiSearch (and VigiFlow)

WHO-ART hierarchy System Organ Class (SOC) group of preferred terms pertaining to the same body organ (32*) High level term (HLT) group of similar preferred terms (184*) Preferred Term (PT) principal terms for coding and presentation (2158*) Included Term (IT) terms similar to preferred terms (3607*) *May 2008

WHO-ART hierarchy - an example SOC Musculo-skeletal system disorders HLT Arthropathy PT Arthritis PT Arthropathy IT Joint inflammation IT Osteoarthritis IT Polyarthropathy IT Joint dysfunction

WHO-ART hierarchy - example II

Complete list of System Organ Classes * RES - Reticuloendothelial system Skin and appendages disorders 0100 Musculo-skeletal system disorders 0200 Collagen disorders 0300 Central & peripheral nervous system disorders 0410 Autonomic nervous system disorders 0420 Vision disorders 0431 Hearing and vestibular disorders 0432 Special senses other, disorders 0433 Psychiatric disorders 0500 Gastro-intestinal system disorders 0600 Liver and biliary system disorders 0700 Metabolic and nutritional disorders 0800 Endocrine disorders 0900 Cardiovascular disorders, general 1010 Myo-, endo-, pericardial & valve disorders 1020 Heart rate and rhythm disorders 1030 Vascular (extracardiac) disorders 1040 Respiratory system disorders 1100 Red blood cell disorders 1210 White cell and RES* disorders 1220 Platelet, bleeding & clotting disorders 1230 Urinary system disorders 1300 Reproductive disorders, male 1410 Reproductive disorders, female 1420 Foetal disorders 1500 Neonatal and infancy disorders 1600 Neoplasms 1700 Body as a whole - general disorders 1810 Application site disorders 1820 Resistance mechanism disorders 1830 Secondary terms - events 2000 Poison specific terms 2100

WHO-ART System Organ Classes Skin and appendages disorders Musculo-skeletal system disorders Collagen disorders etc... 0100 0200 0300 etc... Secondary terms events not likely to be a direct effect of a drug, e.g. medication error, wound infection, burn, fall 2000 Poison terms e.g. foetal alcohol syndrome, silicosis, chemical burn 2100

WHO-ART - Critical terms Definition; A subset of adverse reaction terms referring to, or possibly being indicative of, serious disease states, which have been regarded as particularly important to monitor e.g. Death, anaphylactic shock, convulsions, erythema multiforme

WHO-ART summary WHO-ART makes it easy to sort and search information on ADRs 4 level hierarchial structure Preferred terms are the principle terms for coding and output Multilingual Critical terms list for focus on more serious outcomes

But... what about MedDRA

Features of MedDRA in comparison to WHO-ART More terms in MedDRA More fine granular Easier to give correct description of a reaction More levels in MedDRA Other interesting levels for statistical analysis SMQs (Standardized MedDRA Queries) To simplify analysis when using MedDRA ICH MedDRA Points-to-Consider Documents Developed to facilitate consistent input and output

Structure comparison

Content and mapping comparison MedDRA WHO-ART

MedDRA/WHO-ART grouping Given the differences, how can MedDRA and WHO- ART be used in parallel Reports are always coded on PT/LLT level, same as for WHO-ART where PT/IT is used Multiple MedDRA terms can correspond to the same WHO- ART term (and in rare cases vice versa) Some MedDRA terms representing indications, non ADR events and laboratory tests must be mapped to a generic WHO-ART term The above considerations result in what we call a Grouping Structure!

MedDRA grouping structure Report1 Report2 WA1 M1 WHO-ART view 2 reports 1 term WA2 WA3 M2 M3 M4 M5 M6 MedDRA view 2 reports 2 terms WA4 M7 WA5 M8

WHO Collaborating Centre for International Drug Monitoring Box 1051, SE - 751 40 Uppsala Sweden Tel +46 18 65 60 60, Fax +46 18 65 60 88 E-mail: info@who-umc.org Website: www.who-umc.org